Abstract
Response to ‘Clinical outcomes in NSCLC patients with <i>EGFR</i> mutations: pooled analysis’ (Paz‐Ares <i>et al., J Cell Mol Med</i>. 2010; 14: 51–69)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
